ProCE Banner Activity

Incorporating Guideline-Recommended HER2 Testing Into GI Cancer Management

Slideset

Download these slides on assessment of HER2 overexpression in GI cancers.

Released: May 30, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Seagen Inc.